Grant/GrossMendelsohn, LLC
- SEC CIK
- 0001810677
- Latest filing
- May 1, 2025
PFE holding history
Pfizer Inc in every 13F filed by Grant/GrossMendelsohn, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q1 2025 holdings
- Shares (Q1 2025)
- 20,816
- Value
- $479.8K
- % of portfolio
- 0.3%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 20,816 | $479.8K | 0.3% | −294−1.4% | Reduced | Holders |
| Q4 2024 | 21,110 | $560.1K | 0.3% | +187+0.9% | Added | Holders |
| Q3 2024 | 20,923 | $605.5K | 0.3% | +600+3.0% | Added | Holders |
| Q2 2024 | 20,323 | $568.6K | 0.3% | +60+0.3% | Added | Holders |
| Q1 2024 | 20,263 | $542.6K | 0.3% | −4,539−18.3% | Reduced | Holders |
| Q4 2023 | 24,802 | $681.3K | 0.3% | −3,853−13.4% | Reduced | Holders |
| Q3 2023 | 28,655 | $950.5K | 0.4% | −6,975−19.6% | Reduced | Holders |
| Q2 2023 | 35,630 | $1.28M | 0.5% | +173+0.5% | Added | Holders |
| Q1 2023 | 35,457 | $1.45M | 0.8% | +59+0.2% | Added | Holders |
| Q4 2022 | 35,398 | $1.80M | 0.9% | +160.0% | Added | Holders |
| Q3 2022 | 35,382 | $1.61M | 0.9% | +2,138+6.4% | Added | Holders |
| Q2 2022 | 33,244 | $1.73M | 1.0% | +29+0.1% | Added | Holders |
| Q1 2022 | 33,215 | $1.67M | 0.8% | +8,403+33.9% | Added | Holders |
| Q4 2021 | 24,812 | $1.41M | 1.1% | +16+0.1% | Added | Holders |
| Q3 2021 | 24,796 | $1.07M | 0.8% | +97+0.4% | Added | Holders |
| Q2 2021 | 24,699 | $996.0K | 0.8% | +84+0.3% | Added | Holders |
| Q1 2021 | 24,615 | $951.0K | 0.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.